ACTIVE SESSION TAPE Biotechnology $25M Cap Quant: HOLD

Why Is MetaVia Inc. (MTVA) Stock Down Today?

Updated Nov 22, 2026 7:10 AM ET ยท Prev Close $1.07

Pro Workspace
Last Session Price
$1.01 -5.61%
-$0.06 vs $1.07 prior close
Intraday Range
$1.00 โ€“ $1.10
Open $1.06
Relative Volume
0.22x Avg
38,714 sh
52-Week Range
$0.97 โ€“ $13.42
Benchmark Alpha
-1.97% vs SPY
+0.06% vs QQQ
20-Session Trend -16.9%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

MetaVia Inc. Pulling Back 5.61% on 0.22x Relative Volume

MetaVia Inc. (MTVA) is pulling back 5.61% (-$0.06) to $1.01 on 0.22x average session volume. Relative to benchmarks, MTVA is lagging the S&P 500 by -1.97%. 14-day RSI stands at 38.1, keeping momentum in a bearish regime.

NEWS 70% Weight
MetaVia Announces Completion of Last Patient Visit in Extended 24-Week Phase 1 Part 3A Study of Da-1726

MetaVia Inc. Nasdaq MTVA , a clinical-stage biotechnology company focused on transforming liver-related cardiometabolic diseases, today announced that the last patient has completed the final study visit for its Phase 1

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($1.01) trades relative to 20-day SMA ($1.24) and 50-day SMA ($1.40).

Volume Confirmation
LOW VOLUME (0.22x) Consolidation
Sub-average participation โ€” monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

MTVA lagging the S&P 500 by -1.97%
MTVA Session
-5.61%
$1.01
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: -1.97% Alpha vs QQQ: +0.06% Alpha vs XLV: -5.49%

Options Flow & Execution Desk

Recent MTVA Catalyst Headlines

Verified Wire

1โ€“3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$0.95
Short-term support band
Upper Bound
$1.07
Short-term resistance band
Key Inflection Level
$1.00 (session support)

Monitor volume expansion above 1.5x RVOL around $1.00 (session support) for directional breakout confirmation.

Technical Regime (MTVA)

BEARISH MA TREND
RSI (14)
38.1
Bearish
20-Day SMA
$1.24
Below 20d
50-Day SMA
$1.40
Below 50d
MACD Signal
Bearish
MACD -0.07
ADX (14)
12.7
Weak trend
10d Momentum
-0.42
Soft 10-day momentum

Retail & Crowd Sentiment

Bullish
24h Messages
0
7d avg 1.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

A bullish StockTwits user expresses anticipation for potential volume in $MTVA due to their belief in the company's love for GLP-1 tickers.

Reddit communities: 1 comment (Bullish)

About MetaVia Inc.

MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Da-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 โ€ฆ

Sector
Healthcare
Market Cap
$25M
Employees
8

Get Instant MTVA Catalyst Alerts

Receive an email alert when MTVA triggers an unusual volume breakout, options sweep, or rating shift.

MTVA Session & Catalyst FAQ

Why is MTVA stock down today?

MetaVia Inc. (MTVA) is pulling back 5.61% (-$0.06) to $1.01 on 0.22x average session volume. Relative to benchmarks, MTVA is lagging the S&P 500 by -1.97%. 14-day RSI stands at 38.1, keeping momentum in a bearish regime.

Is MTVA stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 0.22x relative volume (low participation). Our multi-factor model currently rates MTVA as HOLD. Review full valuation, quality, and timing signals on the MTVA Buy or Sell Decision Brief โ†’

What is MTVA's intrinsic value and expected trading range?

At $1.01, MTVA's modeled 1-to-3 session range is $0.95 โ€“ $1.07, with a key inflection level at $1.00 (session support). Compare current price against multi-year cash flow projections in the MTVA Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for MTVA?

RSI at 38.1 reflects soft below-midline momentum. MTVA trades at $1.01 relative to its 20-day SMA ($1.24) and 50-day SMA ($1.40), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs